More about

Polymyalgia Rheumatica

News
December 18, 2023
2 min read
Save

Sarilumab superior to placebo for achieving sustained remission in polymyalgia rheumatica

Sarilumab superior to placebo for achieving sustained remission in polymyalgia rheumatica

Among patients with polymyalgia rheumatica who relapse during glucocorticoid tapering, sarilumab is effective at enabling them achieve sustained remission and lowering cumulative glucocorticoid use, according to data.

News
November 07, 2023
2 min read
Save

Rheumatology referrals often lack key details of patients’ inflammatory arthritis

Rheumatology referrals often lack key details of patients’ inflammatory arthritis

Key details expressing arthralgia duration, morning stiffness or joint examination findings are often missing from rheumatology referral letters for inflammatory arthritis, according to data published in Rheumatology Advances in Practice.

News
May 12, 2023
6 min read
Save

‘Communication and collaboration’ essential to managing polymyalgia rheumatica, GCA

‘Communication and collaboration’ essential to managing polymyalgia rheumatica, GCA

Polymyalgia rheumatica and giant cell arteritis can overlap and resemble one another in diagnosis and disease course, and understanding where one ends and the other begins is critical for rheumatologists and primary care providers alike.

News
May 03, 2023
5 min read
Save

Sarilumab approval may answer ‘significant unmet need’ for steroid sparing in PMR

Sarilumab approval may answer ‘significant unmet need’ for steroid sparing in PMR

The recent FDA approval of sarilumab for the treatment of refractory polymyalgia rheumatica may have a significant and lasting impact on the use of long-term steroids for that condition.

News
April 04, 2023
2 min read
Save

EULAR recommendations for giant cell arteritis, PMR prioritize remission as target

EULAR recommendations for giant cell arteritis, PMR prioritize remission as target

The treatment target for patients with giant cell arteritis or polymyalgia rheumatica should be remission, with vascular damage prevention taking priority in patients with GCA, according to treat-to-target recommendations from EULAR.

News
March 01, 2023
2 min read
Save

FDA approves sarilumab as first biologic to treat polymyalgia rheumatica

FDA approves sarilumab as first biologic to treat polymyalgia rheumatica

The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an inadequate response to, or cannot taper, corticosteroids, according to a press release from Sanofi.

News
December 01, 2022
1 min read
Save

Sarilumab, tapered glucocorticoids improve steroid-resistant polymyalgia rheumatica

Sarilumab, tapered glucocorticoids improve steroid-resistant polymyalgia rheumatica

PHILADELPHIA — Patients with steroid-resistant polymyalgia rheumatica who received sarilumab and tapered glucocorticoids achieved higher remission rates vs. glucocorticoid taper alone, according to data presented at ACR Convergence 2022.

News
April 08, 2021
3 min read
Save

Tocilizumab improves GCA outcomes in patients with polymyalgia, cranial symptoms

Tocilizumab improves GCA outcomes in patients with polymyalgia, cranial symptoms

Tocilizumab improves outcomes in patients with giant cell arteritis who present with polymyalgia rheumatica symptoms only, cranial symptoms only or both at baseline, according to data published in Seminars in Arthritis & Rheumatism.

News
June 18, 2020
4 min read
Save

Patients with rheumatic disease, COVID-19 more likely to require ventilation

Patients with rheumatic disease, COVID-19 more likely to require ventilation

Patients with rheumatic diseases plus COVID-19 are more likely to require mechanical ventilation, but demonstrated similar clinical features and hospitalization rates as those with COVID-19 only, according to data published in the Annals of the Rheumatic Diseases.

News
November 14, 2019
2 min read
Save

Gadolinium-enhanced MRI improves diagnostic accuracy in polymyalgia rheumatica

Gadolinium-enhanced MRI improves diagnostic accuracy in polymyalgia rheumatica

ATLANTA — Gadolinium-enhanced MRI improved diagnostic accuracy in patients with polymyalgia rheumatica and helped predict disease recurrence, according to a presenter here.

View more